For pharmaceutical companies, the Cytocast Digital Twin Cell™ can be a valuable tool, allowing them to test the effectiveness and unforeseen side effects of drugs on multiple tissues, cell lines before initiating clinical trials. By utilizing our technology pharmaceutical companies can save time and resources through minimizing the need for expensive in vitro and in vivo testing. Furthermore, we are seeking partners to conduct pilot studies to test our approach.

For diagnostics company working with genetics, proteomics or transcriptomics data, we can assist in the development step, to turn your data into valuable therapeutic decision support. Our technology enables the integration of multi-omics and patient-specific clinical data into comprehensive model in order to create a digital twin of the patient, facilitating personalized treatment plans.

For medical device companies, we offer collaborative assistance in the development processes to translate and integrate omics data into an easy-to-understand format that provides predictive value to their product. Our solutions can enhance patient outcomes and help drive success in the rapidly evolving healthcare industry.

For personalized treatment providers seeking to develop novel solutions, we can assist in the development process by providing insights and additional features. Our solutions can help increase patient base by targeting a wider range of diseases and testing the effects and side effects of multiple drugs. Our technology offers a precise and personalized approach to treatment, improving treatment efficacy and patient outcomes.